2022 Revenues ($USD) : $2,922,545,000
2022 R&D spend : $271,657,000
2022 Number of Employees : 7,900
Fiscal Year End : 12/31/2021
Company CEO : Norman Schwartz, president and CEO

Bio-Rad manufactures various products for life science research and clinical diagnostic applications. The Hercules, California-based company’s diversified customer base includes universities, research institutions, hospitals, public health and commercial laboratories and biotechnology and pharmaceutical companies. Founded in 1952, Bio-Rad has steadily grown over the decades with a string of acquisitions. The company acquired human control serum supplier Environmental Chemical Specialties in 1976. It acquired AbD Serotec, a research and diagnostics company, in 2013. It bought PCR systems maker RainDance Technologies in 2017. In 2022, Bio-Rad said it would acquire outstanding shares of Warsaw, Poland–based Curiosity Diagnostics for a total consideration of up to $170 million. –BB